Final answer:
A nurse should monitor liver function, platelet count, and pancreatic function in bipolar disorder patients taking divalproex sodium due to risks of hepatotoxicity, blood clotting issues, and pancreatitis.
Step-by-step explanation:
When monitoring a bipolar disorder patient who has been administered divalproex sodium, a nurse should be vigilant about several key health indicators. The most critical ones include liver function, platelet count, and pancreatic function. Liver function tests are crucial because divalproex sodium can cause hepatotoxicity, leading to liver injury. Platelet count is important since the medication can affect blood clotting, potentially leading to bleeding complications. Monitoring pancreatic function is essential because there is a risk of pancreatitis with divalproex sodium use. Signs of liver problems or pancreatitis may include fatigue, fever, joint pain and swelling, decreased kidney function, confusion, and depression, among others. Skin conditions, such as a sunlight-sensitive butterfly rash or skin lesions, can be indicative of serious adverse reactions, although they are less common.